Keywords: Alfa Wassermann, Norgine, Targaxan, Xifaxan, UK launch, Hepatic encephalopathy, Liver disease

Alfa Wassermann and Norgine's Targaxan gets first European launch, in UK

Article | 28 January 2013

Following recent European Union approval (The Pharma Letter December 9, 2012), Netherlands-based Norgine Pharmaceuticals and Italy’s Alfa Wassermann have announced ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in